These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 9154732)
21. [Differentiated use of calcium antagonists. Current therapy of cardiovascular diseases]. Internist (Berl); 1999 Oct; 40(10 Suppl Moderne):1-4. PubMed ID: 10549001 [No Abstract] [Full Text] [Related]
22. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160). Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280 [TBL] [Abstract][Full Text] [Related]
23. The pressure's on. A hypertension drug taken by 28 million people is under scrutiny. What are the other options? Smith IK Time; 2000 Sep; 156(11):126. PubMed ID: 11067229 [No Abstract] [Full Text] [Related]
26. [Drug information about lercanidipine. A new dihydropyridine calcium antagonist for the treatment of arterial hypertension]. Christensen KL Ugeskr Laeger; 2005 Jan; 167(2):153-5. PubMed ID: 15697124 [No Abstract] [Full Text] [Related]
28. Using medication history to measure confounding by indication in assessing calcium channel blockers and other antihypertensive therapy. Leader S; Mallick R; Roht L J Hum Hypertens; 2001 Mar; 15(3):153-9. PubMed ID: 11317198 [TBL] [Abstract][Full Text] [Related]
29. Use of calcium channel blockers as antihypertensives in relation to mortality and cancer incidence: a population-based observational study. Lindberg G; Lindblad U; Löw-Larsen B; Merlo J; Melander A; Råstam L Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):493-7. PubMed ID: 12426934 [TBL] [Abstract][Full Text] [Related]
30. Calcium antagonists in cardiovascular disease: a necessary controversy but an unnecessary panic. Grossman E; Messerli FH Am J Med; 1997 Feb; 102(2):147-9. PubMed ID: 9217563 [No Abstract] [Full Text] [Related]